心臓バイオマーカー検査の世界市場:企業別、地域別、種類別、用途別、市場予測(~2024)

Table of Contents

1 Cardiac Biomarkers Testing Market Overview
1.1 Product Overview and Scope of Cardiac Biomarkers Testing
1.2 Classification of Cardiac Biomarkers Testing by Types
1.2.1 Global Cardiac Biomarkers Testing Revenue Comparison by Types (2019-2024)
1.2.2 Global Cardiac Biomarkers Testing Revenue Market Share by Types in 2018
1.2.3 Myocardial Muscle Creatine Kinase (CK-MB)
1.2.4 Troponins (T and I)
1.2.5 Myoglobin
1.2.6 Brain Natriuretic Peptide (BNPs) or NT-proBNP
1.2.7 Ischemia-modified Albumin (IMA)
1.2.8 Others
1.3 Global Cardiac Biomarkers Testing Market by Application
1.3.1 Global Cardiac Biomarkers Testing Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 Global Cardiac Biomarkers Testing Market by Regions
1.4.1 Global Cardiac Biomarkers Testing Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.5 Global Market Size of Cardiac Biomarkers Testing (2014-2024)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Cardiac Biomarkers Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.2 Becton, Dickinson and Company
2.2.1 Business Overview
2.2.2 Cardiac Biomarkers Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.3 BioMerieux
2.3.1 Business Overview
2.3.2 Cardiac Biomarkers Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioMerieux Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bio-Rad Laboratories, Inc.
2.4.1 Business Overview
2.4.2 Cardiac Biomarkers Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.5 Danaher Corporation
2.5.1 Business Overview
2.5.2 Cardiac Biomarkers Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Danaher Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.6 F. HOFFMANN-LA ROCHE LTD.
2.6.1 Business Overview
2.6.2 Cardiac Biomarkers Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 F. HOFFMANN-LA ROCHE LTD. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.7 Siemens AG
2.7.1 Business Overview
2.7.2 Cardiac Biomarkers Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Siemens AG Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.8 Thermo Fisher Scientific, Inc.
2.8.1 Business Overview
2.8.2 Cardiac Biomarkers Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.9 PerkinElmer Inc.
2.9.1 Business Overview
2.9.2 Cardiac Biomarkers Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.10 Tosoh Corporation
2.10.1 Business Overview
2.10.2 Cardiac Biomarkers Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tosoh Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cardiac Biomarkers Testing Market Competition, by Players
3.1 Global Cardiac Biomarkers Testing Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cardiac Biomarkers Testing Players Market Share
3.2.2 Top 10 Cardiac Biomarkers Testing Players Market Share
3.3 Market Competition Trend
4 Global Cardiac Biomarkers Testing Market Size by Regions
4.1 Global Cardiac Biomarkers Testing Revenue and Market Share by Regions
4.2 North America Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
4.3 Europe Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
4.5 South America Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
5 North America Cardiac Biomarkers Testing Revenue by Countries
5.1 North America Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
5.2 USA Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
5.3 Canada Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
5.4 Mexico Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6 Europe Cardiac Biomarkers Testing Revenue by Countries
6.1 Europe Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
6.2 Germany Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6.3 UK Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6.4 France Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6.5 Russia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6.6 Italy Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cardiac Biomarkers Testing Revenue by Countries
7.1 Asia-Pacific Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
7.2 China Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7.3 Japan Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7.4 Korea Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7.5 India Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
8 South America Cardiac Biomarkers Testing Revenue by Countries
8.1 South America Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
8.2 Brazil Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
8.3 Argentina Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
8.4 Colombia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cardiac Biomarkers Testing by Countries
9.1 Middle East and Africa Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9.3 UAE Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9.4 Egypt Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9.6 South Africa Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
10 Global Cardiac Biomarkers Testing Market Segment by Type
10.1 Global Cardiac Biomarkers Testing Revenue and Market Share by Type (2014-2019)
10.2 Global Cardiac Biomarkers Testing Market Forecast by Type (2019-2024)
10.3 Myocardial Muscle Creatine Kinase (CK-MB) Revenue Growth Rate (2014-2024)
10.4 Troponins (T and I) Revenue Growth Rate (2014-2024)
10.5 Myoglobin Revenue Growth Rate (2014-2024)
10.6 Brain Natriuretic Peptide (BNPs) or NT-proBNP Revenue Growth Rate (2014-2024)
10.7 Ischemia-modified Albumin (IMA) Revenue Growth Rate (2014-2024)
10.8 Others Revenue Growth Rate (2014-2024)
11 Global Cardiac Biomarkers Testing Market Segment by Application
11.1 Global Cardiac Biomarkers Testing Revenue Market Share by Application (2014-2019)
11.2 Cardiac Biomarkers Testing Market Forecast by Application (2019-2024)
11.3 Myocardial Infarction Revenue Growth (2014-2019)
11.4 Congestive Heart Failure Revenue Growth (2014-2019)
11.5 Acute Coronary Syndrome Revenue Growth (2014-2019)
11.6 Atherosclerosis Revenue Growth (2014-2019)
11.7 Others Revenue Growth (2014-2019)
12 Global Cardiac Biomarkers Testing Market Size Forecast (2019-2024)
12.1 Global Cardiac Biomarkers Testing Market Size Forecast (2019-2024)
12.2 Global Cardiac Biomarkers Testing Market Forecast by Regions (2019-2024)
12.3 North America Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
12.4 Europe Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
12.6 South America Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

facebooktwittergoogle_plusredditpinterestlinkedinmail